AMY TURNER: Open Payments
NPI 1215261672 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,580 in 121 payments from 26 companies in 2025. Trend: 2023 $2,849 · 2024 $2,038 · 2025 $2,580
Food & beverage: $2,540Education: $40
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 25 | $550 |
| Novo Nordisk Inc | 13 | $284 |
| Abbott Laboratories | 7 | $177 |
| Amgen Inc. | 11 | $161 |
| Ascendis Pharma Endocrinology Inc | 8 | $147 |
| Corcept Therapeutics | 5 | $138 |
| ABBVIE INC. | 10 | $138 |
| Novartis Pharmaceuticals Corporation | 5 | $115 |
| Insulet Corporation | 5 | $109 |
| SANOFI-AVENTIS U.S. LLC | 3 | $100 |
Products named: MINIMED 780G, Ozempic, FREESTYLE LIBRE 3, Yorvipath, Korlym, TEPEZZA, LEQVIO, Omnipod.
Industry payments across SC — which companies pay providers there.
